Literature DB >> 25368115

Impact of detergent on biophysical properties and immune response of the IpaDB fusion protein, a candidate subunit vaccine against Shigella species.

Xiaotong Chen1, Shyamal P Choudhari1, Francisco J Martinez-Becerra1, Jae Hyun Kim2, Nicholas E Dickenson1, Ronald T Toth2, Sangeeta B Joshi2, Jamie C Greenwood1, John D Clements3, William D Picking1, C Russell Middaugh2, Wendy L Picking4.   

Abstract

Shigella spp. are causative agents of bacillary dysentery, a human illness with high global morbidity levels, particularly among elderly and infant populations. Shigella infects via the fecal-oral route, and its virulence is dependent upon a type III secretion system (T3SS). Two components of the exposed needle tip complex of the Shigella T3SS, invasion plasmid antigen D (IpaD) and IpaB, have been identified as broadly protective antigens in the mouse lethal pneumonia model. A recombinant fusion protein (DB fusion) was created by joining the coding sequences of IpaD and IpaB. The DB fusion is coexpressed with IpaB's cognate chaperone, IpgC, for proper recombinant expression. The chaperone can then be removed by using the mild detergents octyl oligooxyethelene (OPOE) or N,N-dimethyldodecylamine N-oxide (LDAO). The DB fusion in OPOE or LDAO was used for biophysical characterization and subsequent construction of an empirical phase diagram (EPD). The EPD showed that the DB fusion in OPOE is most stable at neutral pH below 55 °C. In contrast, the DB fusion in LDAO exhibited remarkable thermal plasticity, since this detergent prevents the loss of secondary and tertiary structures after thermal unfolding at 90 °C, as well as preventing thermally induced aggregation. Moreover, the DB fusion in LDAO induced higher interleukin-17 secretion and provided a higher protective efficacy in a mouse challenge model than did the DB fusion in OPOE. These data indicate that LDAO might introduce plasticity to the protein, promoting thermal resilience and enhanced protective efficacy, which may be important in its use as a subunit vaccine.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25368115      PMCID: PMC4288857          DOI: 10.1128/IAI.02457-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

Review 1.  Modern analytical ultracentrifugation in protein science: a tutorial review.

Authors:  Jacob Lebowitz; Marc S Lewis; Peter Schuck
Journal:  Protein Sci       Date:  2002-09       Impact factor: 6.725

2.  Improved data visualization techniques for analyzing macromolecule structural changes.

Authors:  Jae Hyun Kim; Vidyashankara Iyer; Sangeeta B Joshi; David B Volkin; C Russell Middaugh
Journal:  Protein Sci       Date:  2012-09-17       Impact factor: 6.725

3.  Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling.

Authors:  P Schuck
Journal:  Biophys J       Date:  2000-03       Impact factor: 4.033

4.  Oligomeric states of the Shigella translocator protein IpaB provide structural insights into formation of the type III secretion translocon.

Authors:  Nicholas E Dickenson; Shyamal P Choudhari; Philip R Adam; Ryan M Kramer; Sangeeta B Joshi; C Russell Middaugh; Wendy L Picking; William D Picking
Journal:  Protein Sci       Date:  2013-03-18       Impact factor: 6.725

5.  Th17 cells are the dominant T cell subtype primed by Shigella flexneri mediating protective immunity.

Authors:  Gernot Sellge; Joao G Magalhaes; Christoph Konradt; Jörg H Fritz; Wilmara Salgado-Pabon; Gérard Eberl; Antonio Bandeira; James P Di Santo; Phillippe J Sansonetti; Armelle Phalipon
Journal:  J Immunol       Date:  2010-01-20       Impact factor: 5.422

Review 6.  Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion.

Authors:  Gunnar N Schroeder; Hubert Hilbi
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

7.  Parenteral immunization with IpaB/IpaD protects mice against lethal pulmonary infection by Shigella.

Authors:  Francisco J Martinez-Becerra; Micah Scobey; Kelly Harrison; Shyamal P Choudhari; Amy M Quick; Sangeeta B Joshi; C Russell Middaugh; Wendy L Picking
Journal:  Vaccine       Date:  2013-04-16       Impact factor: 3.641

8.  The oligomerization domain of C4-binding protein (C4bp) acts as an adjuvant, and the fusion protein comprised of the 19-kilodalton merozoite surface protein 1 fused with the murine C4bp domain protects mice against malaria.

Authors:  Solabomi A Ogun; Laurence Dumon-Seignovert; Jean-Baptiste Marchand; Anthony A Holder; Fergal Hill
Journal:  Infect Immun       Date:  2008-05-12       Impact factor: 3.441

9.  Antibody and cytokine responses in a mouse pulmonary model of Shigella flexneri serotype 2a infection.

Authors:  L L van de Verg; C P Mallett; H H Collins; T Larsen; C Hammack; T L Hale
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

10.  Broadly protective Shigella vaccine based on type III secretion apparatus proteins.

Authors:  Francisco J Martinez-Becerra; Julian M Kissmann; Jovita Diaz-McNair; Shyamal P Choudhari; Amy M Quick; Gabriela Mellado-Sanchez; John D Clements; Marcela F Pasetti; Wendy L Picking
Journal:  Infect Immun       Date:  2011-12-27       Impact factor: 3.441

View more
  10 in total

1.  Characterization and Protective Efficacy of Type III Secretion Proteins as a Broadly Protective Subunit Vaccine against Salmonella enterica Serotypes.

Authors:  Francisco J Martinez-Becerra; Prashant Kumar; Vikalp Vishwakarma; Jae Hyun Kim; Olivia Arizmendi; C Russell Middaugh; William D Picking; Wendy L Picking
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

2.  Detergent Isolation Stabilizes and Activates the Shigella Type III Secretion System Translocator Protein IpaC.

Authors:  Abram R Bernard; Shari M Duarte; Prashant Kumar; Nicholas E Dickenson
Journal:  J Pharm Sci       Date:  2016-06-11       Impact factor: 3.534

3.  Structural Insights of Shigella Translocator IpaB and Its Chaperone IpgC in Solution.

Authors:  Mariana L Ferrari; Spyridoula N Charova; Philippe J Sansonetti; Efstratios Mylonas; Anastasia D Gazi
Journal:  Front Cell Infect Microbiol       Date:  2021-04-29       Impact factor: 5.293

4.  Chlamydia Outer Protein (Cop) B from Chlamydia pneumoniae possesses characteristic features of a type III secretion (T3S) translocator protein.

Authors:  David C Bulir; Daniel A Waltho; Christopher B Stone; Steven Liang; Christopher K W Chiang; Kenneth A Mwawasi; Jordan C Nelson; Steven W Zhang; Samantha P Mihalco; Zachariah C Scinocca; James B Mahony
Journal:  BMC Microbiol       Date:  2015-08-14       Impact factor: 3.605

5.  Chlamydial Type III Secretion System Needle Protein Induces Protective Immunity against Chlamydia muridarum Intravaginal Infection.

Authors:  Ekaterina A Koroleva; Natalie V Kobets; Dmitrii N Shcherbinin; Naylia A Zigangirova; Maxim M Shmarov; Amir I Tukhvatulin; Denis Y Logunov; Boris S Naroditsky; Alexander L Gintsburg
Journal:  Biomed Res Int       Date:  2017-03-26       Impact factor: 3.411

6.  Vaccination With Mouse Dendritic Cells Loaded With an IpaD-IpaB Fusion Provides Protection Against Shigellosis.

Authors:  Olivia Arizmendi; Prashant Kumar; Qi Zheng; Jason P Stewart; William D Picking; Wendy Picking; Francisco J Martinez-Becerra
Journal:  Front Immunol       Date:  2019-02-08       Impact factor: 7.561

7.  Development of a Broadly Protective, Self-Adjuvanting Subunit Vaccine to Prevent Infections by Pseudomonas aeruginosa.

Authors:  Sayan Das; Debaki R Howlader; Qi Zheng; Siva Sai Kumar Ratnakaram; Sean K Whittier; Ti Lu; Johnathan D Keith; William D Picking; Susan E Birket; Wendy L Picking
Journal:  Front Immunol       Date:  2020-11-17       Impact factor: 7.561

8.  Structurally Related Liposomes Containing N-Oxide Surfactants: Physicochemical Properties and Evaluation of Antimicrobial Activity in Combination with Therapeutically Available Antibiotics.

Authors:  Sara Battista; Pierangelo Bellio; Lorenza Fagnani; Elena Allegritti; Lisaurora Nazzicone; Luciano Galantini; Giuseppe Celenza; Luisa Giansanti
Journal:  Mol Pharm       Date:  2022-02-16       Impact factor: 4.939

9.  Addition of Lauryldimethylamine N-Oxide (LDAO) to a Copper-Free Click Chemistry Reaction Improves the Conjugation Efficiency of a Cell-Free Generated CRM197 Variant to Clinically Important Streptococcus pneumoniae Serotypes.

Authors:  Leslie Bautista; Lucy Pill-Pepe; Neeraj Kapoor; Scott Snyder; Ellen Chu; Paresh Agarwal; Mohammed Sardar; Shylaja Arulkumar; Aym Berges; Mark Iverson; Christopher Behrens; Olivier Marcq; Jeff Fairman
Journal:  ACS Omega       Date:  2022-09-20

10.  Preformulation Characterization and the Effect of Ionic Excipients on the Stability of a Novel DB Fusion Protein.

Authors:  Akshay Jain; Gang Hu; Siva Sai Kumar Ratnakaram; David K Johnson; William D Picking; Wendy L Picking; Charles Russell Middaugh
Journal:  J Pharm Sci       Date:  2020-09-08       Impact factor: 3.534

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.